FALL 2018 SYMPOSIUM

Here's the program book, program book insert (front) and program book insert (back) from our fall 2018 symposium as well as a film of the symposium.

ONEINFORTY SYMPOSIUM
Knowledge is Empowering:
Understanding the Jewish - Cancer Connection
Wednesday, November 7th, 7:00 - 9:00 p.m.
Temple Sinai
25 Canton St.
Sharon, MA 02067

Temple Sinai, located in Sharon, Massachusetts, hosted this Oneinforty symposium to educate the community about Ashkenazi Jews' one-in-forty risk of inheriting a BRCA gene mutation. Having a BRCA gene mutation significantly increases one's risk of developing breast, ovarian, prostate and other cancers that, in many cases, can be prevented or detected early.

Panelists discussed genetic counseling, the rationale for testing for BRCA gene mutations, managing cancer risk and resources available for those who carry BRCA gene mutations. Attendees also learned about the BRCA Founder Outreach (BFOR) Study being conducted by Dana-Farber Cancer Institute, Beth Israel Deaconess Medical Center, Memorial Sloan Kettering, Cedars-Sinai Medical Center, Penn Medicine and the Basser Center for BRCA. Jewish individuals who have a BRCA gene mutation shared their stories. Following presentations by each of the panelists listed below, there was a Q&A session.

Betty Cooperstein, LICSW
In private practice in Brookline & Wayland, MA

Lauren Corduck
Founder & Executive Director
Oneinforty
BRCA-positive ovarian cancer survivor

Joi Morris, JD
Senior Vice President, Alliances & General Counsel
HeritX

Melissa Rosen
Director of National Outreach
Sharsheret

Nadine Tung, MD
Director, Cancer Genetics and Prevention Program
Director, Breast Medical Oncology
Principal Investigator, BRCA Founder Outreach (BFOR) Study
Beth Israel Deaconess Medical Center

Oneinforty symposia are free-of-charge and open to the general public. Kosher refreshments are served.

Questions? Please contact Lauren Corduck at 617-823-3630 or laurenc@oneinforty.org

Presented by Oneinforty, a nonprofit organization that raises awareness of the one-in-forty risk to Ashkenazi Jews of inheriting BRCA gene mutations and provides the support individuals and families need to effectively manage their cancer risk.

Download a PDF of Oneinforty's fall 2018 symposium flyer